Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing since 12/18/2024, newest first.
| Issuer | % of Class | Filed | |||
|---|---|---|---|---|---|
|
Alignment Healthcare, Inc.
13G
ALHC · 01625V104
|
5.3% |
7/10/2025
Event 7/2/2025
|
|||
| Citadel Advisors LLC | 4.7% | ||||
| Citadel Advisors Holdings LP | 4.7% | ||||
| Citadel GP LLC | 4.7% | ||||
| Citadel Securities LLC | 0.6% | ||||
| Citadel Securities Group LP | 0.6% | ||||
| Citadel Securities GP LLC | 0.6% | ||||
| Kenneth Griffin | 5.3% | ||||
|
Nano Labs Ltd
13G
NA · G6391Y128
|
9.5% |
7/7/2025
Event 6/27/2025
|
|||
| Citadel Advisors LLC | 9.3% | ||||
| Citadel Advisors Holdings LP | 9.3% | ||||
| Citadel GP LLC | 9.3% | ||||
| Citadel Securities LLC | 0.2% | ||||
| Citadel Securities Group LP | 0.2% | ||||
| Citadel Securities GP LLC | 0.2% | ||||
| Kenneth Griffin | 9.5% | ||||
|
Cabaletta Bio, Inc.
13G
CABA · 12674W109
|
5.2% |
6/20/2025
Event 6/12/2025
|
|||
| Citadel Advisors LLC | 5.0% | ||||
| Citadel Advisors Holdings LP | 5.0% | ||||
| Citadel GP LLC | 5.0% | ||||
| Citadel Securities LLC | 0.1% | ||||
| Citadel Securities Group LP | 0.1% | ||||
| Citadel Securities GP LLC | 0.1% | ||||
| Kenneth Griffin | 5.2% | ||||
|
ADT Inc.
13G
ADT · 00090Q103
|
5.6% |
5/19/2025
Event 5/12/2025
|
|||
| Citadel Advisors LLC | 5.3% | ||||
| Citadel Advisors Holdings LP | 5.3% | ||||
| Citadel GP LLC | 5.3% | ||||
| Citadel Securities LLC | 0.3% | ||||
| Citadel Securities Group LP | 0.3% | ||||
| Citadel Securities GP LLC | 0.3% | ||||
| Kenneth Griffin | 5.6% | ||||
|
Sphere Entertainment Co.
13G/A
Amendment 1
SPHR · 55826T102
|
3.9% |
5/15/2025
Event 3/31/2025
|
|||
| Citadel Advisors LLC | 2.5% | ||||
| Citadel Advisors Holdings LP | 2.5% | ||||
| Citadel GP LLC | 2.5% | ||||
| Citadel Securities LLC | 0.9% | ||||
| Citadel Securities Group LP | 1.3% | ||||
| Citadel Securities GP LLC | 1.3% | ||||
| Kenneth Griffin | 3.9% | ||||
|
FrontView REIT, Inc.
13G/A
Amendment 1
FVR · 35922N100
|
2.4% |
5/15/2025
Event 3/31/2025
|
|||
| Citadel Advisors LLC | 2.1% | ||||
| Citadel Advisors Holdings LP | 2.1% | ||||
| Citadel GP LLC | 2.1% | ||||
| Citadel Securities LLC | 0.3% | ||||
| Citadel Securities Group LP | 0.3% | ||||
| Citadel Securities GP LLC | 0.3% | ||||
| Kenneth Griffin | 2.4% | ||||
|
Ventyx Biosciences, Inc.
13G/A
Amendment 4
VTYX · 92332V107
|
2.0% |
5/15/2025
Event 3/31/2025
|
|||
| Citadel Advisors LLC | 2.0% | ||||
| Citadel Advisors Holdings LP | 2.0% | ||||
| Citadel GP LLC | 2.0% | ||||
| Citadel Securities LLC | 0% | ||||
| Citadel Securities Group LP | 0% | ||||
| Citadel Securities GP LLC | 0% | ||||
| Kenneth Griffin | 2.0% | ||||
|
VYNE Therapeutics Inc.
13G/A
Amendment 2
VYNE · 92941V308
|
7.2% |
5/15/2025
Event 3/31/2025
|
|||
| Citadel Advisors LLC | 6.8% | ||||
| Citadel Advisors Holdings LP | 6.8% | ||||
| Citadel GP LLC | 6.8% | ||||
| Citadel Securities LLC | 0.4% | ||||
| Citadel Securities Group LP | 0.4% | ||||
| Citadel Securities GP LLC | 0.4% | ||||
| Kenneth Griffin | 7.2% | ||||
|
Chain Bridge Bancorp, Inc.
13G/A
Amendment 1
CBNA · 15746L100
|
0.4% |
5/15/2025
Event 3/31/2025
|
|||
| Citadel Advisors LLC | 0% | ||||
| Citadel Advisors Holdings LP | 0% | ||||
| Citadel GP LLC | 0% | ||||
| Citadel Securities LLC | 0.4% | ||||
| Citadel Securities Group LP | 0.4% | ||||
| Citadel Securities GP LLC | 0.4% | ||||
| Kenneth Griffin | 0.4% | ||||
|
UWM Holdings Corporation
13G/A
Amendment 2
UWMC · 91823B109
|
6.6% |
5/15/2025
Event 3/31/2025
|
|||
| Citadel Advisors LLC | 6.0% | ||||
| Citadel Advisors Holdings LP | 6.0% | ||||
| Citadel GP LLC | 6.0% | ||||
| Citadel Securities LLC | 0.3% | ||||
| Citadel Securities Group LP | 0.6% | ||||
| Citadel Securities GP LLC | 0.6% | ||||
| Kenneth Griffin | 6.6% | ||||
|
Acrivon Therapeutics, Inc.
13G/A
Amendment 3
ACRV · 004890109
|
6.0% |
5/15/2025
Event 3/31/2025
|
|||
| Citadel Advisors LLC | 6.0% | ||||
| Citadel Advisors Holdings LP | 6.0% | ||||
| Citadel GP LLC | 6.0% | ||||
| Citadel Securities LLC | 0% | ||||
| Citadel Securities Group LP | 0% | ||||
| Citadel Securities GP LLC | 0% | ||||
| Kenneth Griffin | 6.0% | ||||
|
Spirit Aviation Holdings, Inc.
13G
FLYYQ · 84863V101
|
9.9% |
5/6/2025
Event 4/29/2025
|
|||
| Citadel Advisors LLC | 9.9% | ||||
| Citadel Advisors Holdings LP | 9.9% | ||||
| Citadel GP LLC | 9.9% | ||||
| Citadel Securities LLC | 0% | ||||
| Citadel Securities Group LP | 0% | ||||
| Citadel Securities GP LLC | 0% | ||||
| Kenneth Griffin | 9.9% | ||||
|
DBV Technologies S.A.
13G
DBVT · 23306J309
|
6.4% |
4/14/2025
Event 4/7/2025
|
|||
| Citadel Advisors LLC | 6.4% | ||||
| Citadel Advisors Holdings LP | 6.4% | ||||
| Citadel GP LLC | 6.4% | ||||
| Citadel Securities LLC | 0% | ||||
| Citadel Securities Group LP | 0% | ||||
| Citadel Securities GP LLC | 0% | ||||
| Kenneth Griffin | 6.4% | ||||
|
Aardvark Therapeutics, Inc.
13G
AARD · 002942100
|
5.6% |
2/24/2025
Event 2/14/2025
|
|||
| Citadel Advisors LLC | 5.4% | ||||
| Citadel Advisors Holdings LP | 5.4% | ||||
| Citadel GP LLC | 5.4% | ||||
| Citadel Securities LLC | 0.2% | ||||
| Citadel Securities Group LP | 0.2% | ||||
| Citadel Securities GP LLC | 0.2% | ||||
| Kenneth Griffin | 5.6% | ||||
|
Sun Country Airlines Holdings, Inc.
13G
SNCY · 866683105
|
6.1% |
2/19/2025
Event 2/11/2025
|
|||
| Citadel Advisors LLC | 5.9% | ||||
| Citadel Advisors Holdings LP | 5.9% | ||||
| Citadel GP LLC | 5.9% | ||||
| Citadel Securities LLC | 0.2% | ||||
| Citadel Securities Group LP | 0.2% | ||||
| Citadel Securities GP LLC | 0.2% | ||||
| Kenneth Griffin | 6.1% | ||||
|
COMPASS Pathways plc
13G/A
Amendment 1
CMPS · 20451W101
|
1.7% |
2/14/2025
Event 12/31/2024
|
|||
| Citadel Advisors LLC | 1.3% | ||||
| Citadel Advisors Holdings LP | 1.3% | ||||
| Citadel GP LLC | 1.3% | ||||
| Citadel Securities LLC | 0.4% | ||||
| Citadel Securities Group LP | 0.4% | ||||
| Citadel Securities GP LLC | 0.4% | ||||
| Kenneth Griffin | 1.7% | ||||
|
Terns Pharmaceuticals, Inc.
13G/A
Amendment 1
TERN · 880881107
|
4.1% |
2/14/2025
Event 12/31/2024
|
|||
| Citadel Advisors LLC | 3.9% | ||||
| Citadel Advisors Holdings LP | 3.9% | ||||
| Citadel GP LLC | 3.9% | ||||
| Citadel Securities LLC | 0.2% | ||||
| Citadel Securities Group LP | 0.2% | ||||
| Citadel Securities GP LLC | 0.2% | ||||
| Kenneth Griffin | 4.1% | ||||
|
Protara Therapeutics, Inc.
13G/A
Amendment 1
TARA · 74365U107
|
4.7% |
2/14/2025
Event 12/31/2024
|
|||
| Citadel Advisors LLC | 4.6% | ||||
| Citadel Advisors Holdings LP | 4.6% | ||||
| Citadel GP LLC | 4.6% | ||||
| Citadel Securities LLC | 0% | ||||
| Citadel Securities Group LP | 0% | ||||
| Citadel Securities GP LLC | 0% | ||||
| Kenneth Griffin | 4.7% | ||||
|
Lyra Therapeutics, Inc.
13G/A
Amendment 2
LYRA · 55234L105
|
0% |
2/14/2025
Event 12/31/2024
|
|||
| Citadel Advisors LLC | 0% | ||||
| Citadel Advisors Holdings LP | 0% | ||||
| Citadel GP LLC | 0% | ||||
| Citadel Securities LLC | 0% | ||||
| Citadel Securities Group LP | 0% | ||||
| Citadel Securities GP LLC | 0% | ||||
| Kenneth Griffin | 0% | ||||
|
Korro Bio, Inc.
13G/A
Amendment 2
KRRO · 500946108
|
3.9% |
2/14/2025
Event 12/31/2024
|
|||
| Citadel Advisors LLC | 3.9% | ||||
| Citadel Advisors Holdings LP | 3.9% | ||||
| Citadel GP LLC | 3.9% | ||||
| Citadel Securities LLC | 0% | ||||
| Citadel Securities Group LP | 0% | ||||
| Citadel Securities GP LLC | 0% | ||||
| Kenneth Griffin | 3.9% | ||||
|
Hawaiian Electric Industries Inc
13G/A
Amendment 1
HE · 419870100
|
0.4% |
2/14/2025
Event 12/31/2024
|
|||
| Citadel Advisors LLC | 0% | ||||
| Citadel Advisors Holdings LP | 0% | ||||
| Citadel GP LLC | 0% | ||||
| Citadel Securities LLC | 0.2% | ||||
| Citadel Securities Group LP | 0.4% | ||||
| Citadel Securities GP LLC | 0.4% | ||||
| Kenneth Griffin | 0.4% | ||||
|
ACELYRIN, Inc.
13G/A
Amendment 2
SLRN · 00445A100
|
4.2% |
2/14/2025
Event 12/31/2024
|
|||
| Citadel Advisors LLC | 4.2% | ||||
| Citadel Advisors Holdings LP | 4.2% | ||||
| Citadel GP LLC | 4.2% | ||||
| Citadel Securities LLC | 0% | ||||
| Citadel Securities Group LP | 0% | ||||
| Citadel Securities GP LLC | 0% | ||||
| Kenneth Griffin | 4.2% | ||||
|
Arvinas, Inc.
13G/A
Amendment 1
ARVN · 04335A105
|
5.1% |
2/14/2025
Event 1/23/2025
|
|||
| Citadel Advisors LLC | 4.8% | ||||
| Citadel Advisors Holdings LP | 4.8% | ||||
| Citadel GP LLC | 4.8% | ||||
| Citadel Securities LLC | 0.2% | ||||
| Citadel Securities Group LP | 0.3% | ||||
| Citadel Securities GP LLC | 0.3% | ||||
| Kenneth Griffin | 5.1% | ||||
|
Arvinas, Inc.
13G
ARVN · 04335A105
|
5.1% |
1/30/2025
Event 1/23/2025
|
|||
| Citadel Advisors LLC | 4.8% | ||||
| Citadel Advisors Holdings LP | 4.8% | ||||
| Citadel GP LLC | 4.8% | ||||
| Citadel Securities LLC | 0.2% | ||||
| Citadel Securities Group LP | 0.3% | ||||
| Citadel Securities GP LLC | 0.3% | ||||
| Kenneth Griffin | 5.1% | ||||